E-LIB Suche - Ergebnisse für: Harris, Erik D.

1

Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improv..:

Dahlmann, Mathias ; Monks, Anne ; Harris, Erik D....
Cancers. 14 (2021) 1 - p. 37 , 2021

Link: https://doi.org/10.3390/..

2

ATR inhibition reverses the resistance of homologous recomb..:

El Touny, Lara H. ; Hose, Curtis ; Connelly, John...
Oncotarget. 12 (2021) 21 - p. 2114-2130 , 2021

Link: https://doi.org/10.18632..

3

Exposure time versus cytotoxicity for anticancer agents:

Evans, David M. ; Fang, Jianwen ; Silvers, Thomas...
Cancer Chemotherapy and Pharmacology. 84 (2019) 2 - p. 359-371 , 2019

Link: https://doi.org/10.1007/..

4

Characterization of potent and selective iodonium-class inh..:

Lu, Jiamo ; Risbood, Prabhakar ; Kane Jr, Charles T....
Biochemical Pharmacology. 143 (2017) - p. 25-38 , 2017

Link: https://doi.org/10.1016/..

5

Small Cell Lung Cancer Screen of Oncology Drugs, Investigat..:

Polley, Eric ; Kunkel, Mark ; Evans, David...
Journal of the National Cancer Institute. 108 (2016) 10 - p. djw122 , 2016

Link: https://doi.org/10.1093/..

6

The Metastasis-Associated Gene S100A4 Is a Novel Target of ..:

Stein, Ulrike ; Arlt, Franziska ; Walther, Wolfgang...
Gastroenterology. 131 (2006) 5 - p. 1486-1500 , 2006

Link: https://doi.org/10.1053/..

7

UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in..:

Monks, Anne ; Harris, Erik D. ; Vaigro-Wolff, Anne...
Investigational New Drugs. 18 (2000) 2 - p. 95-107 , 2000

Link: https://doi.org/10.1023/..

8

Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improv..:

Dahlmann, Mathias ; Monks, Anne ; Harris, Erik D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750436/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Exposure time versus cytotoxicity for anticancer agents:

Evans, David M ; Fang, Jianwen ; Silvers, Thomas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127868/. , 2019

Link: http://www.ncbi.nlm.nih...

10

The NCI Transcriptional Pharmacodynamics Workbench: a tool ..:

Monks, Anne ; Zhao, Yingdong ; Hose, Curtis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295263/. , 2018

Link: http://www.ncbi.nlm.nih...

11

Characterization of Potent and Selective Iodonium-Class Inh..:

Lu, Jiamo ; Risbood, Prabhakar ; Kane, Charles T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610936/. , 2017

Link: http://www.ncbi.nlm.nih...

12

Small Cell Lung Cancer Screen of Oncology Drugs, Investigat..:

Polley, Eric ; Kunkel, Mark ; Evans, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279282/. , 2016

Link: http://www.ncbi.nlm.nih...

13

Sarcoma Cell Line Screen of Oncology Drugs and Investigatio..:

Teicher, Beverly A ; Polley, Eric ; Kunkel, Mark...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636476/. , 2015

Link: http://www.ncbi.nlm.nih...

14

Correction: Identification of specific calcitonin-like rece..:

Banerjee, Sugato ; Evanson, Janel ; Harris, Erik...
http://www.biomedcentral.com/1471-2210/6/14. , 2006

Link: http://www.biomedcentral..

15

Identification of specific calcitonin-like receptor residue..:

Banerjee, Sugato ; Evanson, Janel ; Harris, Erik...
http://www.biomedcentral.com/1471-2210/6/9. , 2006

Link: http://www.biomedcentral..